Soothing the Logistical Headache of Clinical Trials
As many as 30% of subjects taking part in Phase III clinical studies drop out of such studies. Gruelling schedules, high travel costs and the time taken to be reimbursed for expenses are all factors in these high fall-out rates, and this can be very problematic; delaying or even leading to the cancellation of a trial. Franc Jeffrey at Equilibrium Travel Management discusses why it is crucial to keep subjects motivated, and how this can be achieved through efficient management of travel and other expenses.
http://jforcs.com/jcs/wp-content/uploads/edd/2012/11/3-Soothing-the-Logistical-Headache-of-Clinical-Trials.pdf